Simwave – a global leader in maritime training and assessment with a highly specialized center for the maritime industry – has partnered with VIKAND – a global leader in maritime medical operations and healthcare solutions – to create the world’s first Maritime School of Medicine and Public Health, which includes a customized Infectious Disease Control Officer Training Program to meet the industry’s demand for improved onboard safety due to the COVID pandemic.
“COVID-19 has highlighted the vital role of public health, medical expertise, and knowledge in ensuring a safe maritime working environment. Together with Simwave, VIKAND is launching a specially designed curriculum to deliver the latest evidence-based knowledge on infection prevention and control,” says Peter Hult, Managing Director of VIKAND. “We believe a rigorous, maritime-specific curriculum will prepare the cruise, yacht, commercial shipping, and river transport sectors for future and ongoing public health challenges,” he continues.
Marcel Kind, CEO of Simwave, comments: “This partnership brings medical and public health training to maritime operators worldwide. The aim is to familiarize participants with medical and public health challenges and provide them with the appropriate knowledge, skills, and attitude. The initiative builds on medical and public health expertise and knowledge; together we are developing a cutting-edge medical and public health training module that will offer both online and in-person curricula,” Marcel continues.
“In 2021, the Vikand School of Maritime Medicine and Public Health, powered by Simwave, was launched. Our goals are to provide guidance and expertise to help maritime industries prevent the transmission of diseases, including COVID-19, develop and improve training to refocus protocols, and, above all, foster leadership through expertise in infection prevention and control. We are excited about the project and privileged to work with Marcel and his team to deliver this program, so that we are all better prepared for future challenges,” concludes Peter Hult.
